COR - Cencora, Inc.
260.93
1.230 0.471%
Share volume: 1,795,184
Last Updated: 05-12-2026
Wholesale/Wholesale – Drugs & Drug Proprietaries:
0.04%
PREVIOUS CLOSE
CHG
CHG%
$259.70
1.23
0.00%
Fundamental analysis
54%
Profitability
45%
Dept financing
37%
Liquidity
44%
Performance
70%
Performance
5 Days
-0.06%
1 Month
-18.23%
3 Months
-27.69%
6 Months
-28.60%
1 Year
-6.48%
2 Year
4.10%
Key data
Stock price
$260.93
DAY RANGE
$259.07 - $264.92
52 WEEK RANGE
$244.82 - $377.54
52 WEEK CHANGE
-$6.53
DIVIDEND
$0.60
EX-DIVIDEND DATE
05-15-2026
NEXT EARNINGS DATE
07-30-2025
Company detail
CEO: Steven H. Collis
Region: US
Website: www.cencora.com
Employees: 42,000
IPO year: 1995
Issue type:
Market: NYSE
Industry: Wholesale/Wholesale – Drugs & Drug Proprietaries
Sector: Wholesale Trade
Region: US
Website: www.cencora.com
Employees: 42,000
IPO year: 1995
Issue type:
Market: NYSE
Industry: Wholesale/Wholesale – Drugs & Drug Proprietaries
Sector: Wholesale Trade
Cencora, Inc. sources and distributes pharmaceutical products. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.
Recent news